NeuroOne Medical Technologies Corporation (NMTC) Net income 2016–2025
NeuroOne Medical Technologies Corporation (NMTC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$3.6MFY2025 · since FY2016: -$47,775 → -$3.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.6M | +70.7% |
| FY2024 | -$12.3M | -3.9% |
| FY2023 | -$11.9M | -18.6% |
| FY2022 | -$10.0M | -0.5% |
| FY2021 | -$9.9M | +27.1% |
| FY2020 | -$13.6M | -194.2% |
| FY2019 | -$4.6M | — |
| FY2017 | -$5.1M | -10488.0% |
| FY2016 | -$47,775 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NMTC financial trends
NMTC RevenueNMTC Net marginNMTC Gross profitNMTC Gross marginNMTC Operating incomeNMTC Operating marginNMTC Operating cash flowNMTC Free cash flowNMTC Capital expendituresNMTC Return on equityNMTC Stock buybacksNMTC Dividends paidNMTC Total assetsNMTC Total liabilitiesNMTC Shareholders’ equityNMTC overview →